SBI Securities’s Creative Medical Technology CELZ Stock Holding History

SBI Securities’s Portfolio CELZ Stock Details CELZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1	Sell	1 -42	-98%	-$42	﹤0.01%	4107
2026 Q2	$62	Buy	43 +42	+4,200%	+$91	﹤0.01%	3622
2026 Q1	$2	Hold	1	–	–	﹤0.01%	3957
2025 Q4	$2	Hold	1	–	–	﹤0.01%	3968
2025 Q3	$3	Buy	+1	New	+$3	﹤0.01%	4126

Other funds holding CELZ

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

SBI Securities's CELZ Position: Q3 2026 in Review

SBI Securities reduced its Creative Medical Technology (CELZ) stake by 98% in Q3 2026, selling an estimated $42 and leaving 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4107.

SBI Securities first reported a position in CELZ in Q3 2025 and has held it in 5 quarters since. The position peaked at $62 in Q2 2026. 4 funds tracked by Wall St. Rank hold CELZ as of Q3 2026.

SBI Securities held 1 share of Creative Medical Technology worth $1 as of Q3 2026.
SBI Securities sold 42 Creative Medical Technology shares in Q3 2026, an estimated $42.
Creative Medical Technology made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #4107 holding.
SBI Securities first reported a position in Creative Medical Technology in Q3 2025 and has held it in 5 quarters since.
SBI Securities's Creative Medical Technology position peaked at $62 in Q2 2026.
4 funds tracked by Wall St. Rank held Creative Medical Technology as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.